Report on the delegation of power under Regulation (EC) No 273/2004 on drug precursors and Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Union and third countries in drug precursors

Background and further information:

Regulation (EU) No 273/2004 establishes harmonised measures for the intra-Union control and monitoring of certain substances frequently used for the illicit manufacture of narcotic drugs and psychotropic substances (hereinafter referred to as drug precursors) for the purpose of preventing the diversion of such substances. Regulation (EU) No 111/2005 lays down rules for the monitoring of trade between the Union and third countries in the above-mentioned substances. It applies to imports, exports and intermediary activities.

Both Regulations empower the Commission to adopt delegated acts for certain purposes and under certain conditions for a period of five years from 30 December 2013, and call on the Commission to present a report to the European Parliament and to the Council in respect of the delegation of power conferred on it not later than nine months before the end of the five-year period, i.e. by 31 March 2018.

In view of the close material link between those Regulations, the amendments to both have been adopted by way of single delegated acts covering both Regulations. Consequently, the two above-mentioned reporting requirements have also been merged into one report. During the period under consideration, namely from 30 December 2013 to the date of adoption of this report, the Commission exercised its power to adopt delegated acts three times.